Oruka Therapeutics (ORKA) Misses Q4 EPS by 49c
Tweet
Share
E-mailGet Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics (NASDAQ: ORKA) reported Q4 EPS of ($0.49).
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Doncasters (DPC) indicating open around $40, IPO priced at $33
- Natural Gas Inventory 76 bcf vs 69 bcf Expected
- DeepSeek plans to double workforce amid $7.4 billion raise
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
